Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Medical imaging technologies have undergone explosive growthover the past few decades and now play a central role in clinicaloncology. But the truly transformative power of imaging in theclinical management of cancer patients lies ahead. Today, imagingis at a crossroads, with molecularly targeted imaging agentsexpected to broadly expand the capabilities of conventionalanatomical imaging methods. Molecular imaging will allow cliniciansto not only see where a tumor is located in the body, but alsoto visualize the expression and activity of specific molecules(e.g., proteases and protein kinases) and biological processes(e.g., apoptosis, angiogenesis, and metastasis) that influencetumor behavior and/or response to therapy. This informationis expected to have a major impact on cancer detection, individualizedtreatment, and drug development, as well as our understandingof how cancer arises.
Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
INTRODUCTION TO SPECIAL ISSUE
Paula A. Kiberstis and John Travis (26 May 2006) Science312 (5777), 1157.
[DOI: 10.1126/science.312.5777.1157] |Summary »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Improvement of Biodistribution and Therapeutic Index via Increase of Polyethylene Glycol on Drug-carrying Liposomes in an HT-29/luc Xenografted Mouse Model.
T.-H. CHOW, Y.-Y. LIN, J.-J. HWANG, H.-E. WANG, Y.-L. TSENG, S.-J. WANG, R.-S. LIU, W.-J. LIN, C.-S. YANG, and G. TING (2009)
Anticancer Res
29, 2111-2120
|Abstract »|Full Text »|PDF »
Molecular biomimetics: nanotechnology and bionanotechnology using genetically engineered peptides.
Human Breast Cancer Tumor Models: Molecular Imaging of Drug Susceptibility and Dosing during HER2/neu-targeted Therapy.
M. S. Gee, R. Upadhyay, H. Bergquist, H. Alencar, F. Reynolds, M. Maricevich, R. Weissleder, L. Josephson, and U. Mahmood (2008)
Radiology
248, 925-935
|Abstract »|Full Text »|PDF »
Cholangiocarcinoma: Current and Novel Imaging Techniques.
N. I. Sainani, O. A. Catalano, N.-S. Holalkere, A. X. Zhu, P. F. Hahn, and D. V. Sahani (2008)
RadioGraphics
28, 1263-1287
|Abstract »|Full Text »|PDF »
An Official ATS Conference Proceedings: Advances in Small-Animal Imaging Application to Lung Pathophysiology.
R. H. Brown, C. G. Irvin, G. B. Allen III, S. D. Shapiro, W. J. Martin, M. R. J. Kolb, D. M. Hyde, G. F. Nieman, D. D. Cody, M. Ishii, et al. (2008)
Proceedings of the ATS
5, 591-600
|Full Text »|PDF »
Noninvasive molecular imaging of small living subjects using Raman spectroscopy.
S. Keren, C. Zavaleta, Z. Cheng, A. de la Zerda, O. Gheysens, and S. S. Gambhir (2008)
PNAS
105, 5844-5849
|Abstract »|Full Text »|PDF »
A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry.
N. Kronqvist, J. Lofblom, A. Jonsson, H. Wernerus, and S. Stahl (2008)
Protein Eng. Des. Sel.
21, 247-255
|Abstract »|Full Text »|PDF »
Fluorescence resonance energy transfer in near-infrared fluorescent oligonucleotide probes for detecting protein-DNA interactions.
S. Zhang, V. Metelev, D. Tabatadze, P. C. Zamecnik, and A. Bogdanov Jr (2008)
PNAS
105, 4156-4161
|Abstract »|Full Text »|PDF »
Application of Nanotechnology in Cancer Therapy and Imaging.
X. Wang, L. Yang, Z. Chen, and D. M. Shin (2008)
CA Cancer J Clin
58, 97-110
|Abstract »|Full Text »|PDF »
Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.
W. Kemmner, K. Wan, S. Ruttinger, B. Ebert, R. Macdonald, U. Klamm, and K. T. Moesta (2008)
FASEB J
22, 500-509
|Abstract »|Full Text »|PDF »
Changes in 18F-FDG Uptake Within Minutes After Chemotherapy in a Rabbit VX2 Tumor Model.
S.-L. Song, J.-J. Liu, G. Huang, Z.-H. Wang, Y.-Y. Song, X.-G. Sun, and T. Chen (2008)
J. Nucl. Med.
49, 303-309
|Abstract »|Full Text »|PDF »
Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis.
M. Nahrendorf, H. Zhang, S. Hembrador, P. Panizzi, D. E. Sosnovik, E. Aikawa, P. Libby, F. K. Swirski, and R. Weissleder (2008)
Circulation
117, 379-387
|Abstract »|Full Text »|PDF »
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions.
M. Nahrendorf, F. K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger, J.-L. Figueiredo, P. Libby, R. Weissleder, and M. J. Pittet (2007)
J. Exp. Med.
204, 3037-3047
|Abstract »|Full Text »|PDF »
Evaluation of Staphylococcal Cell Surface Display and Flow Cytometry for Postselectional Characterization of Affinity Proteins in Combinatorial Protein Engineering Applications.
J. Lofblom, J. Sandberg, H. Wernerus, and S. Stahl (2007)
Appl. Envir. Microbiol.
73, 6714-6721
|Abstract »|Full Text »|PDF »
Molecular Imaging of Cardiovascular Disease.
F. A. Jaffer, P. Libby, and R. Weissleder (2007)
Circulation
116, 1052-1061
|Full Text »|PDF »
Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo.
O. A. Andreev, A. D. Dupuy, M. Segala, S. Sandugu, D. A. Serra, C. O. Chichester, D. M. Engelman, and Y. K. Reshetnyak (2007)
PNAS
104, 7893-7898
|Abstract »|Full Text »|PDF »
Dual Channel Optical Tomographic Imaging of Leukocyte Recruitment and Protease Activity in the Healing Myocardial Infarct.
M. Nahrendorf, D. E. Sosnovik, P. Waterman, F. K. Swirski, A. N. Pande, E. Aikawa, J.-L. Figueiredo, M. J. Pittet, and R. Weissleder (2007)
Circ. Res.
100, 1218-1225
|Abstract »|Full Text »|PDF »
Molecular Magnetic Resonance Imaging in Cardiovascular Medicine.
D. E. Sosnovik, M. Nahrendorf, and R. Weissleder (2007)
Circulation
115, 2076-2086
|Full Text »|PDF »
Targeting Tyrosine Kinases in Cancer: The Second Wave..
